OCUL Competitors & Alternatives
Compare Ocular Therapeutix Inc with similar stocks in the same industry
Biotechnology
OCUL
Main Stock$9.88
Tradestie Score
63
Market Cap
$1.92B
Revenue Growth
0.0%
Analyst Upside
+174.2%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$27.12
|
$2.37B | - | 57 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$133.82
|
$2.35B | - | 57 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 54 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$75.98
|
$2.33B | - | 64 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$40.55
|
$2.33B | - | 59 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.30
|
$2.23B | - | 53 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.02
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.29
|
$2.21B | - | 54 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$26.48
|
$2.18B | - | 64 | Compare |
More OCUL Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry